Journal of Skin and Stem Cell

Published by: Kowsar

Effect of Hydroquinone Plus Neodymium-Doped Yttrium Aluminium Garnet Laser With and Without CO2 Fractional Laser on Resistant Dermal Melasma

Abbas Zamanian 1 , Elham Behrangi 1 , Gholam Hossein Ghafarpour 1 , Golnaz Mehran 1 , Romina Espahbodi 2 , Tanaz Hoseinzade Fakhim 1 , * and Zahra Azizian 1
Authors Information
1 Department of Dermatology, Rasoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran
2 Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Iran
Article information
  • Journal of Skin and Stem Cell: June 1, 2015, 2 (2); e30290
  • Published Online: June 23, 2015
  • Article Type: Research Article
  • Received: May 31, 2015
  • Accepted: June 6, 2015
  • DOI: 10.17795/jssc30290

To Cite: Zamanian A, Behrangi E, Ghafarpour G H, Mehran G, Espahbodi R, et al. Effect of Hydroquinone Plus Neodymium-Doped Yttrium Aluminium Garnet Laser With and Without CO2 Fractional Laser on Resistant Dermal Melasma, J Skin Stem Cell. 2015 ; 2(2):e30290. doi: 10.17795/jssc30290.

Copyright © 2015, Skin and Stem Cell Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Tamega Ade A, Miot LD, Bonfietti C, Gige TC, Marques ME, Miot HA. Clinical patterns and epidemiological characteristics of facial melasma in Brazilian women. J Eur Acad Dermatol Venereol. 2013; 27(2): 151-6[DOI][PubMed]
  • 2. Miot LD, Miot HA, Silva MG, Marques ME. [Physiopathology of melasma]. An Bras Dermatol. 2009; 84(6): 623-35[PubMed]
  • 3. Gupta AK, Gover MD, Nouri K, Taylor S. The treatment of melasma: a review of clinical trials. J Am Acad Dermatol. 2006; 55(6): 1048-65[DOI][PubMed]
  • 4. Cestari T, Arellano I, Hexsel D, Ortonne JP, Latin American Pigmentary Disorders A. Melasma in Latin America: options for therapy and treatment algorithm. J Eur Acad Dermatol Venereol. 2009; 23(7): 760-72[DOI][PubMed]
  • 5. Alsaad SM, Ross EV, Mishra V, Miller L. A split face study to document the safety and efficacy of clearance of melasma with a 5 ns q switched Nd YAG laser versus a 50 ns q switched Nd YAG laser. Lasers Surg Med. 2014; 46(10): 736-40[DOI][PubMed]
  • 6. Wattanakrai P, Mornchan R, Eimpunth S. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser for the treatment of facial melasma in Asians. Dermatol Surg. 2010; 36(1): 76-87[DOI][PubMed]
  • 7. Jalaly NY, Valizadeh N, Barikbin B, Yousefi M. Low-power fractional CO(2) laser versus low-fluence Q-switch 1,064 nm Nd:YAG laser for treatment of melasma: a randomized, controlled, split-face study. Am J Clin Dermatol. 2014; 15(4): 357-63[DOI][PubMed]
  • 8. Goldberg DJ. Laser Treatment of Pigmented Lesions. Dermatol Clin. 1997; 15(3): 397-407
  • 9. Anderson RR, Margolis RJ, Watenabe S, Flotte T, Hruza GJ, Dover JS. Selective photothermolysis of cutaneous pigmentation by Q-switched Nd: YAG laser pulses at 1064, 532, and 355 nm. J Invest Dermatol. 1989; 93(1): 28-32[PubMed]
  • 10. Nelson JS, Applebaum J. Treatment of Superficial Cutaneous Pigmented Lesions by Melanin-specific Selective Photothermolysis Using the Q-switched Ruby Laser. Ann Plastic Surg. 1992; 29(3): 231-7
  • 11. Goldberg DJ. Benign pigmented lesions of the skin. Treatment with the Q-switched ruby laser. J Dermatol Surg Oncol. 1993; 19(4): 376-9[PubMed]
  • 12. Haddad AL, Matos LF, Brunstein F, Ferreira LM, Silva A, Costa DJ. A clinical, prospective, randomized, double-blind trial comparing skin whitening complex with hydroquinone vs. placebo in the treatment of melasma. Int J Dermatol. 2003; 42(2): 153-6[PubMed]
  • 13. Fabi SG, Friedmann DP, Niwa Massaki AB, Goldman MP. A randomized, split-face clinical trial of low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser versus low-fluence Q-switched alexandrite laser (755 nm) for the treatment of facial melasma. Lasers Surg Med. 2014; 46(7): 531-7[DOI][PubMed]
  • 14. Bansal C, Naik H, Kar HK, Chauhan A. A Comparison of Low-Fluence 1064-nm Q-Switched Nd: YAG Laser with Topical 20% Azelaic Acid Cream and their Combination in Melasma in Indian Patients. J Cutan Aesthet Surg. 2012; 5(4): 266-72[DOI][PubMed]
  • 15. Kim HS, Kim EK, Jung KE, Park YM, Kim HO, Lee JY. A split-face comparison of low-fluence Q-switched Nd: YAG laser plus 1550 nm fractional photothermolysis vs. Q-switched Nd: YAG monotherapy for facial melasma in Asian skin. J Cosmet Laser Ther. 2013; 15(3): 143-9[DOI][PubMed]
  • 16. Grimes PE. Melasma. Arch Dermatol. 1995; 131(12): 1453
  • 17. Hexsel D, Lacerda DA, Cavalcante AS, Machado Filho CA, Kalil CL, Ayres EL, et al. Epidemiology of melasma in Brazilian patients: a multicenter study. Int J Dermatol. 2014; 53(4): 440-4[DOI][PubMed]
  • 18. Bartoli Miot LD, Amante Miot H, Da Silva MG, Marques ME. Physiopathology of melisma. An Bras Dermatol. 2009; 84(6)
  • 19. Grimes PE. Management of Hyperpigmentation in Darker Racial Ethnic Groups. Sem Cutan Med Surg. 2009; 28(2): 77-85[DOI]
  • 20. Arora P, Sarkar R, Garg VK, Arya L. Lasers for treatment of melasma and post-inflammatory hyperpigmentation. J Cutan Aesthet Surg. 2012; 5(2): 93-103[DOI][PubMed]
  • 21. Rathi SK, Achar A. Melasma: A clinico-epidemiological study of 312 cases. Indian J Dermatol. 2011; 56(4): 380-2[DOI]
  • 22. Jeong SY, Shin JB, Yeo UC, Kim WS, Kim IH. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet laser for melasma with pre- or post-treatment triple combination cream. Dermatol Surg. 2010; 36(6): 909-18[DOI][PubMed]
  • 23. Chan NP, Ho SG, Shek SY, Yeung CK, Chan HH. A case series of facial depigmentation associated with low fluence Q-switched 1,064 nm Nd:YAG laser for skin rejuvenation and melasma. Lasers Surg Med. 2010; 42(8): 712-9[DOI][PubMed]
  • 24. Polnikorn N. Treatment of refractory dermal melasma with the MedLite C6 Q-switched Nd:YAG laser: two case reports. J Cosmet Laser Ther. 2008; 10(3): 167-73[DOI][PubMed]
  • 25. Berlin AL, Dudelzak J, Hussain M, Phelps R, Goldberg DJ. Evaluation of clinical, microscopic, and ultrastructural changes after treatment with a novel Q-switched Nd:YAG laser. J Cosmet Laser Ther. 2008; 10(2): 76-9[DOI][PubMed]
  • 26. Kim MJ, Kim JS, Cho SB. Punctate leucoderma after melasma treatment using 1064-nm Q-switched Nd:YAG laser with low pulse energy. J Eur Acad Dermatol Venereol. 2009; 23(8): 960-2[DOI][PubMed]
  • 27. Manaloto RMP, Alster T. Erbium:YAG Laser Resurfacing for Refractory Melasma. Dermatol Surg. 1999; 25(2): 121-3
  • 28. Palumbo A, D'Ischia M, Misuraca G, Prota G. Mechanism of inhibition of melanogenesis by hydroquinone. Biochimica et Biophysica Acta (BBA) - General Subjects. 1991; 1073(1): 85-90[DOI]
  • 29. Amer M, Metwalli M. Topical hydroquinone in the treatment of some hyperpigmentary disorders. Int J Dermatol. 1998; 37(6): 449-50[PubMed]
  • 30. Vachiramon V, Sirithanabadeekul P, Sahawatwong S. Low-fluence Q-switched Nd: YAG 1064-nm laser and intense pulsed light for the treatment of melasma. J Eur Acad Dermatol Venereol. 2015; 29(7): 1339-46[DOI][PubMed]
  • 31. Ball Arefiev KL, Hantash BM. Advances in the treatment of melasma: a review of the recent literature. Dermatol Surg. 2012; 38(7 Pt 1): 971-84[DOI][PubMed]
  • 32. Choi CP, Yim SM, Seo SH, Ahn HH, Kye YC, Choi JE. Retrospective analysis of melasma treatment using a dual mode of low-fluence Q-switched and long-pulse Nd:YAG laser vs. low-fluence Q-switched Nd:YAG laser monotherapy. J Cosmet Laser Ther. 2015; 17(1): 2-8[DOI][PubMed]
  • 33. Park KY, Kim DH, Kim HK, Li K, Seo SJ, Hong CK. A randomized, observer-blinded, comparison of combined 1064-nm Q-switched neodymium-doped yttrium-aluminium-garnet laser plus 30% glycolic acid peel vs. laser monotherapy to treat melasma. Clin Expe Dermatol. 2011; 36(8): 864-70[DOI]
  • 34. Lee DB, Suh HS, Choi YS. A comparative study of low-fluence 1,064 nm Q-Switched Nd:YAG laser with or without chemical peeling using Jessner's solution in melasma patients. J Cosmet Laser Ther. 2014; 16(6): 264-70[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments